-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MenDNsDqyYtwzqhMdL0BP/c6GoINUVJACMd+go0clf46aWR8DCPRWt8VWnlW9NvP 6vzLasZV7+MUGOE3WtgRSw== 0001331514-09-000003.txt : 20090807 0001331514-09-000003.hdr.sgml : 20090807 20090807113423 ACCESSION NUMBER: 0001331514-09-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090807 DATE AS OF CHANGE: 20090807 EFFECTIVENESS DATE: 20090807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aureon Laboratories Inc CENTRAL INDEX KEY: 0001331514 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-78598 FILM NUMBER: 09994132 BUSINESS ADDRESS: STREET 1: 28 WELLS AVE CITY: NEW YORK STATE: NY ZIP: 10701 BUSINESS PHONE: 914-377-4000 MAIL ADDRESS: STREET 1: 28 WELLS AVE CITY: NEW YORK STATE: NY ZIP: 10701 D 1 primary_doc.xml X0502 D LIVE 0001331514 Aureon Laboratories Inc 28 WELLS AVE NEW YORK NY 10701 914-377-4000 Aurigen Bioscience, Inc. Aureon Biosciences Corporation DELAWARE Corporation true Jose Costa, M.D. 20 York Street East Pavilion, Room 2-607 New Haven CT 06520 Director Philippe Chambon, M.D., Ph.D. c/o New Leaf Venture Partners, LLC 7 Times Square, Suite 1603 New York NY 10036 Director Peter Barrett, Ph.D. c/o Atlas Venture 890 Winter Street, Suite 320 Waltham MA 02451 Director Robert Shovlin c/o Aureon Laboratories, Inc. 28 Wells Avenue Yonkers NY 10701 Executive Officer Director Kevin Johnson c/o Aureon Laboratories, Inc. 28 Wells Avenue Yonkers NY 10701 Director Jose Velasco, M.D. c/o Aureon Laboratories, Inc. 28 Wells Avenue Yonkers NY 10701 Director Carlos Cordon-Cardo, M.D., Ph.D. 1250 First Avenue, Suite 801 New York NY 10021 Director Vijay Aggarwal, Ph.D. c/o Aureon Laboratories, Inc. 28 Wells Avenue Yonkers NY 10701 Director Biotechnology Decline to Disclose 06 false 2009-07-29 false true true true false 0 8000000 4000000 4000000 false 16 0 0 0 false Aureon Laboratories Inc /s/ Robert Shovlin Robert Shovlin President and CEO 2009-08-07 -----END PRIVACY-ENHANCED MESSAGE-----